Format

Send to

Choose Destination
See comment in PubMed Commons below
Ideggyogy Sz. 2006 May 20;59(5-6):179-82.

[Experience with levetiracetam in childhood epilepsy].

[Article in Hungarian]

Author information

1
Magyar Református Egyház Bethesda Gyermekkórháza, Budapest. neuwirth.magda@bethesda.hu

Abstract

OBJECTIVE:

To evaluate the efficacy and tolerability of levetiracetam in children with drug resistant epilepsy from a retrospective study.

METHODS:

We report the result of a study of 85 pediatric patients (mean 10.5 years, range: 1-24) with refractory generalized and focal epilepsy, who received levetiracetam as add-on treatment. The average duration of epilepsy was eight years, and the patient were treated with mean of 6.0 antiepileptic drugs before levetiracetam was introduced.

RESULTS:

Ten patients (12%) became seizure-free, three (3%) responded with seizure reduction of more than 90%, 32 (38%) responded with seizure reduction of more than 50% following introduction of levetiracetam. No response to levetiracetam was reported in 34% (n: 29). Positive psychotropic effect was observed in 26 patient (30%). Mild to moderate side effects were reported in 11 patients (13%), consisting most frequently general behavioral changes, aggression, sleep disturbances, but they ceased after decreasing the dose of levetiracetam. Mental retardation was associated with poor response and associated with more side effects.

CONCLUSION:

Levetiracetam is a well tolerated new antiepileptic drug that may effectively improve seizures control as an add-on drug in resistant epilepsy in childhood with good tolerability.

PMID:
16786712
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center